期刊文献+

Fascaplysin抑制ICR小鼠体内S180移植瘤的分子机制初探 被引量:1

Preliminary Study on Anti-tumor Mechanism of Fascaplysin on Sarcoma Mice Model
下载PDF
导出
摘要 目的研究fascaplysin对ICR小鼠S180移植瘤生长的体内抑制作用,并初步探讨fascaplysin在体内抑瘤的分子机制。方法皮下注射技术建立荷S180骨肉瘤的ICR小鼠为实体瘤动物模型,然后将其分为4组:即空白对照组(注射生理盐水)、阳性对照组[CTX,30mg/(kg.d)]、fascaplysin高剂量组[20mg/(kg.d)]和fascaplysin低剂量组[5mg/(kg.d)],处理10天后,利用电镜分析各组小鼠移植瘤细胞的变化,应用免疫组化技术检测相应组织PCNA、CD31表达情况。结果电镜结果显示肿瘤组织细胞出现凋亡现象。PCNA结果发现,fascaplysin治疗组与空白对照组相比差异极显著(P<0.01),高、低剂量组之间差异显著(P<0.05),具有一定程度的剂量-效应依赖性。MVD结果:与空白对照组相比,fascaplysin各剂量组肿瘤组织内MVD均明显减少(P<0.01)。结论 Fascaplysin治疗能诱导肿瘤细胞凋亡,减少肿瘤组织PCNA的表达,降低肿瘤的增殖活性。减少肿瘤组织微血管的密度,抑制肿瘤血管的新生。提示fascaplysin在体内具有良好的抗肿瘤作用。 Objective To study the inhibitory effects of fascaplysin on the growth of S180 transplanted tumor in ICR mice, and to explore the anti - tumor mechanism of fascaplysin in vivo. Methods A sarcoma mice model was established, and the mice were divided into four groups, including control group ( injected with 0.9% NaC1), positive group [ injected with 30rag/( kg . d) cyclophosphamide], high dose group [ received 20mg/( kg . d) fascaplysin], and low dose group [ 5mg/( kg.d) fascaplysin ]. After treated with fascaplysin for 10 days, the tumor tissues were examined morphologically by transmission electron microscope. Tissue sections were also immunostained with monoclonal antibody directed to proliferating cell nuclear antigen (PCNA) and CD31 to detect the proliferating activity of tumor cells and the distribution of micro vessels. Results Typical apoptotic phenomena were observed by transmission electron microscope. Immunohistochemical test results showed that the expression of PCNA in the two fascaplysin groups was decreased significantly compared with that of the blank control (P 〈 0.01 ). And the difference between the low dose group and high dose group was also significant ( P 〈 0. 05 ), which indicated that Fascaplysin decreased the expression of PCNA in S180 transplanted tumor of ICR mice in a dose - effect dependent manner. Microvessel density (MVD) assay indicated that the MVD in the two Fascaplysin groups was decreased significantly compared with that of the blank control, P 〈 0.01. Conclusion From these findings, it can be considered that fascaplysin can inhibit the growth of S180 cell implanted tumor, and the action mechanisms may involve in apoptosis and anti angiogenesis.
出处 《医学研究杂志》 2012年第5期35-39,共5页 Journal of Medical Research
基金 国家自然科学基金资助项目(30800860) 浙江省自然科学基金资助项目(Y5100066) 宁波市自然科学基金资助项目(2010A610028)
关键词 Fascaplysin S180移植瘤PCNA CD31 Faseaplysin S180 transplanted tumor PCNA CD31
  • 相关文献

参考文献12

  • 1Roll DM, Ireland CM, Lu HSM, et al. Fascaplysin, an unusual anti- microbial pigment from the marine sponge fascaplysinopsis sp [ J ], J Org Chem, 1988, 53 : 3276 - 3278.
  • 2Radchenko OS, Novikov VL, Elyakov GB. A simple and practical ap- proach to the synthesis of the marine sponge pigment fascaplysin andrelated compounds[ J]. Tetrahedron Lett, 1997, 38 : 5339 - 5342.
  • 3LuWS. Advance of tumor suppressor p16 [ J]. J Anhui Institute Edu, 2003, 21 (3): 63-65.
  • 4Hormann A, Chauduri B. DNA binding properties of the marine sponge pigment fascaplysin[ J]. Bioorgan Med Chem, 2001, 9 : 917 -921.
  • 5Lin J, Yan XJ, Chen HM. Fascaplysin, a selective CDK4 inhibitor, exhibit antiangiogenic activity in vitro and in vivo [ J]. Cancer Che- moth Pharm, 2007, 59 : 439 - 445.
  • 6Subramanian B, Nakeff A, Tenney K, et al. A new paradigm for the development of anticancer agents from natural products[ J]. J Exp T- her Oncol, 2006, 5:195-204.
  • 7卢晓玲,郑燕玲,陈海敏,严小军,王峰,徐炜烽.Fascaplysin通过诱导细胞凋亡抑制HeLa细胞体外增殖[J].药学学报,2009,44(9):980-986. 被引量:9
  • 8Shivji KK, Kenny MK, Wood RD. Proliferating cell nuclear antigen isrequired for DNA excision repair [J]. Cell, 1992, 69(2) : 367 - 374.
  • 9Deepak AV, Salimath BP. Antiangiogenic and proapoptotic activity of a novel glycoprotein from U. indica is mediated by NF - KB and caspase activated DNase in ascites tumor model[J]. Biochimie,2006, 88:297 - 307.
  • 10鲁文胜.抑癌基因p16的研究进展[J].安徽教育学院学报,2003,21(3):63-65. 被引量:4

二级参考文献47

  • 1孙纪元,王四旺,朱妙章,谢艳华,缪珊.苦马豆素诱导人胃癌细胞SGC-7901凋亡作用机制的实验研究(英文)[J].中国临床药理学与治疗学,2005,10(9):978-983. 被引量:13
  • 2Alvarez-Salas LM, DiPaolo JA. Molecular approaches to cervical cancer therapy [J]. Curr Drug Discov Technol, 2007, 4: 208-219.
  • 3Schwartsmann G, Ratain M J, Cragg GM, et al. Anticancer drug discovery and development throughout the world [J]. J Clin Oncol, 2002, 20: 47S-59S.
  • 4Roll DM, Ireland CM, Lu HSM, et al. Fascaplysin, an unusual antimicrobial pigment from the marine sponge Fascaplysinopsis sp [J]. J Org Chem, 1988, 53: 3276- 3278.
  • 5Segraves NL, Lopez S, Johnson TA, et al. Structures and cytotoxicities of fascaplysin and related alkaloids from two marine phyla--Fascaplysinopsis sponges and Didemnum tunicates [J]. Tetrahedron Lett, 2003, 44: 3471-3475.
  • 6Soni R, Muller L, Furet P, et al. Inhibition of cyclindependent kinase 4 (Cdk4) by fascaplysin, a marine natural product [J]. Biochem Biopbys Res Commun, 2000, 275: 877-884.
  • 7Lin J, Yan X J, Chen HM. Fascaplysin, a selective CDK4 inhibitor, exhibit anti-angiogenic activity in vitro and in vivo [J]. Cancer Chemother Pharmacol, 2007, 59: 439-445.
  • 8Subramanian B, Nakeff A, Tenney K, et al. A new paradigm for the development of anticancer agents from natural products [J]. J lExp Ther Oncol, 2006, 5: 195-204.
  • 9Calbo J, Serna C, Garriga J, et al. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity [J]. Cell Death Differ, 2004, 11 1055-1065.
  • 10Shapiro GI, Harper JW. Anticancer drug targets: cell cycle and checkpoint control [J]. J Clin Invest, 1999, 104: 1645-1653.

共引文献10

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部